pubrio
SHANGHAI HAOHAI BIOLOGICAL TECHNOLOGY CO., LTD. logo

SHANGHAI HAOHAI BIOLOGICAL TECHNOLOGY CO., LTD.

Public
3healthcare.com
研究行业2,200+ employeesFounded 2007🇨🇳 中国

Haohai Biological Technology (06826.HK) is a leading company in China focusing on R&D, manufacturing and sales of biomedical materials. We strategically target the fast-growing therapeutic areas in the biomedical materials market including ophthalmology, medical aesthetics and would healing, orthopedics, and anti-adhesion and hemostasis. We currently manufacture intraocular lens (IOL), medical sodium hyaluronate, medical chitosan, medical collage sponge, rhEGF, etc. Based on the sales volume of the Company's IOL and the number of national cataract surgery cases, the Company has captured about 30% of the IOL market in the PRC. Meanwhile, the market share of Company's anti-adhesion products, OVD products and orthopedics viscosupplementation products was 49.05%, 45.93%, and 36.21%, respectively.

成立年份
2007
员工人数
2,200+
行业
研究行业
公司类型
Public Company
股票
shh: 688366.SS
总部
🇨🇳4f, No 2 Building, Alley 139, Shanghai, China (+1)
专长
研究行业

扩张情报

全新 · 仅在 Pubrio

我们正在追踪 SHANGHAI HAOHAI BIOLOGICAL TECHNOLOGY CO., LTD. 的市场扩张

全球扩张

实时
阶段
探索中投入中进入中运营中
了解一下

关于 SHANGHAI HAOHAI BIOLOGICAL TECHNOLOGY CO., LTD. 的常见问题

关于 SHANGHAI HAOHAI BIOLOGICAL TECHNOLOGY CO., LTD. 的业务、市场和增长信号的快速解答。

Haohai Biological Technology (06826.HK) is a leading company in China focusing on R&D, manufacturing and sales of biomedical materials. We strategically target the fast-growing therapeutic areas in the biomedical materials market including ophthalmology, medical aesthetics and would healing, orthopedics, and anti-adhesion and hemostasis. We currently manufacture intraocular lens (IOL), medical sodium hyaluronate, medical chitosan, medical collage sponge, rhEGF, etc. Based on the sales volume of the Company's IOL and the number of national cataract surgery cases, the Company has captured about 30% of the IOL market in the PRC. Meanwhile, the market share of Company's anti-adhesion products, OVD products and orthopedics viscosupplementation products was 49.05%, 45.93%, and 36.21%, respectively.

今天就开启旅程

可以先用平台,也可以先聊聊

你可以自行使用 Pubrio,或让我们的团队协助研究、获客或数据整合。

与团队沟通
Start Journey Image
pubrio

Pubrio 将来自 50+ 本地来源的商业、人物与意向数据整合为全球图谱,帮助 AI 与营收团队洞悉全市场。

© 2026 Pubrio。保留所有权利。